NeuroTherapeutics Pharma

About:

NeuroTherapeutics Pharma develops therapeutics for patients suffering from central nervous system disorders.

Top Investors: F-Prime Capital, GlaxoSmithKline, SR One, Pfizer Venture Investments, MPM Capital

Description:

NeuroTherapeutics Pharma, Inc., a biopharmaceutical company, develops therapeutics for patients suffering from central nervous system disorders. It focuses on epilepsy, neuropathic, and acute pain disorders of the nervous system. The company was incorporated in 2006 and is based in Chicago, Illinois.

Total Funding Amount:

$60.7M

Headquarters Location:

Chicago, Illinois, United States

Founded Date:

2006-01-01

Founders:

Stephen Collins

Number of Employees:

11-50

Last Funding Date:

2011-12-15

IPO Status:

Private

Industries: